Feb. 11, 2020 15:00 UTC Medtech industry veteran of two IPOs on the Nasdaq Stock Market (HeartWare, Avedro) CLICHY, France--( BUSINESS WIRE )-- CorWave, a medtech company focused on the development of an innovative Left Ventricular Assist Device (LVAD) to treat patients suffering from severe heart failure, announced today the election of Jim Schuermann to its board of directors. Schuermann was instrumental in transforming HeartWare, an LVAD start-up valued around $10
February 11, 2020
· 2 min read